|
1.Coultas, L., K. Chawengsaksophak, et al.(2005). "Endothelial cells and VEGF in vascular development." Nature 438(7070): 937-945. 2.Folkman, J. (1995). "Angiogenesis in cancer, vascular, rheumatoid and other disease." Nat Med 1(1): 27-31. 3.Yancopoulos, G. D., S. Davis, et al. (2000). "Vascular-specific growth factors and blood vessel formation." Nature 407(6801): 242-248. 4.Auerbach, W. and R. Auerbach (1994). "Angiogenesis inhibition: a review." Pharmacol Ther 63(3): 265-311. 5.Colville-Nash, P. R. and D. A. Willoughby (1997). "Growth factors in angiogenesis: current interest and therapeutic potential." Mol Med Today 3(1): 14-23. 6.Gerhardt, H., M. Golding, et al. (2003). "VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia." J Cell Biol 161(6): 1163-1177. 7.Jain, R. K. (2003). "Molecular regulation of vessel maturation." Nat Med 9(6): 685-693. 8.Karamysheva, A. F. (2008). "Mechanisms of angiogenesis." Biochemistry (Mosc) 73(7): 751-762. 9.Folkman, J. (1971). "Tumor angiogenesis: therapeutic implications." N Engl J Med 285(21): 1182-1186. 10.O'Reilly, M. S., L. Holmgren, et al. (1994). "Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma." Cell 79(2): 315-328. 11.Bergers, G. and L. E. Benjamin (2003). "Tumorigenesis and the angiogenic switch." Nat Rev Cancer 3(6): 401-410. 12.Hashizume, H., P. Baluk, et al. (2000). "Openings between defective endothelial cells explain tumor vessel leakiness." Am J Pathol 156(4): 1363-1380. 13.Oye, K. S., G. Gulati, et al. (2008). "A novel method for mapping the heterogeneity in blood supply to normal and malignant tissues in the mouse dorsal window chamber." Microvasc Res 75(2): 179-187. 14.Folkman, J. (1972). "Anti-angiogenesis: new concept for therapy of solid tumors." Ann Surg 175(3): 409-416. 15.Kieran, M. W. and A. Billett (2001). "Antiangiogenesis therapy. Current and future agents." Hematol Oncol Clin North Am 15(5): 835-851, viii. 16.Ribatti, D., A. Vacca, et al. (2006). "Angiogenesis and anti-angiogenesis in hepatocellular carcinoma." Cancer Treat Rev 32(6): 437-444. 17.Sandison, J., D. (1928). "The transparent chamber of the rabbit’s ear giving a complete description of improved techniques of construction and introduction and general account of growth and behavior of living cells and tissues seen with the microscope. " Am J Anat 41(3):447–472. 18.Algire, G.,H. (1943). "An adaptation of the transparent chamber technique to the mouse. " J Natl Cancer Inst 4:1–11 19.Koehl, G. E., A. Gaumann, et al. (2009). "Intravital microscopy of tumor angiogenesis and regression in the dorsal skin fold chamber: mechanistic insights and preclinical testing of therapeutic strategies." Clin Exp Metastasis 26(4): 329-344. 20.Kiessling, F., D. Razansky, et al. (2010). "Anatomical and microstructural imaging of angiogenesis." Eur J Nucl Med Mol Imaging. 21.Alexander, S., G. E. Koehl, et al. (2008). "Dynamic imaging of cancer growth and invasion: a modified skin-fold chamber model." Histochem Cell Biol 130(6): 1147-1154. 22.Workman, P., E. O. Aboagye, et al. (2010). "Guidelines for the welfare and use of animals in cancer research." British Journal of Cancer 102(11): 1555-1577. 23.Gross, S. and D. Piwnica-Worms (2005). "Spying on cancer: Molecular imaging in vivo with genetically encoded reporters." Cancer Cell 7(1): 5-15. 24.Qiu, L. R., X. M. Ding, et al. (2005). "Confocal measurement approach for enhancing lateral resolution using a phase-only pupil." 7th International Symposium on Measurement Technology and Intelligent Instruments 13: 422-425,480. 25.Lunt, S. J., C. Gray, et al. (2010). "Application of intravital microscopy in studies of tumor microcirculation." J Biomed Opt 15(1): 011113. 26.Jia, W. C., V. Sun, et al. (2010). "Long-Term Blood Vessel Removal With Combined Laser and Topical Rapamycin Antiangiogenic Therapy: Implications for Effective Port Wine Stain Treatment." Lasers in Surgery and Medicine 42(2): 105-112. 27.Lang, S. A., A. Gaumann, et al. (2007). "Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model." Int J Cancer 120(8): 1803-1810. 28.Bernier, J., E. J. Hall, et al. (2004). "Radiation oncology: a century of achievements." Nat Rev Cancer 4(9): 737-747. 29.Rosen, E. M., S. Fan, et al. (1999). "The molecular and cellular basis of radiosensitivity: implications for understanding how normal tissues and tumors respond to therapeutic radiation." Cancer Invest 17(1): 56-72. 30.Camphausen, K. and C. Menard (2002). "Angiogenesis inhibitors and radiotherapy of primary tumours." Expert Opin Biol Ther 2(5): 477-481. 31.Garcia-Barros, M., F. Paris, et al. (2003). "Tumor response to radiotherapy regulated by endothelial cell apoptosis." Science 300(5622): 1155-1159. 32.Moeller, B. J., Y. Cao, et al. (2004). "Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules." Cancer Cell 5(5): 429-441. 33.Frankl, O. and P. Kimball (1914). "U¨ber die Beeinflussung von Ma¨usetumoren durch Ro¨ntgenstrahlen." Wien Klin Wochenschr 27:1448-50. 34.Stenstrom, K. W., H. Vermund, et al. (1955). "Effects of roentgen irradiation on the tumor bed. I. The inhibiting action of local pretransplantation roentgen irradiation (1500 r alpha) on the growth of mouse mammary carcinoma." Radiat Res 2(2): 180-191. 35.Rofstad, E. K., B. Mathiesen, et al. (2005). "The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products." Cancer Res 65(6): 2387-2396. 36.Milas, L., N. Hunter, et al. (1987). "The tumor bed effect: dependence of tumor take, growth rate, and metastasis on the time interval between irradiation and tumor cell transplantation." Int J Radiat Oncol Biol Phys 13(3): 379-383. 37.Milas, L., J. Wike, et al. (1987). "Macrophage content of murine sarcomas and carcinomas: associations with tumor growth parameters and tumor radiocurability." Cancer Res 47(4): 1069-1075. 38.Ito, H., T. Barkley, Jr., et al. (1985). "Modification of tumor response to cyclophosphamide and irradiation by preirradiation of the tumor bed: prolonged growth delay but reduced curability." Int J Radiat Oncol Biol Phys 11(3): 547-553. 39.Riesterer, O., K. A. Mason, et al. (2009). "Enhanced response to C225 of A431 tumor xenografts growing in irradiated tumor bed." Radiother Oncol 92(3): 383-387. 40.Parangi, S., W. Dietrich, et al. (1995). "Tumor suppressor loci on mouse chromosomes 9 and 16 are lost at distinct stages of tumorigenesis in a transgenic model of islet cell carcinoma." Cancer Res 55(24): 6071-6076. 41.Cheng, S. Y., M. Nagane, et al. (1997). "Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189." Proc Natl Acad Sci U S A 94(22): 12081-12087. 42.Abramsson, A., O. Berlin, et al. (2002). "Analysis of mural cell recruitment to tumor vessels." Circulation 105(1): 112-117. 43.Baluk, P., H. Hashizume, et al. (2005). "Cellular abnormalities of blood vessels as targets in cancer." Current Opinion in Genetics & Development 15(1): 102-111. 44.Maniotis, A. J., R. Folberg, et al. (1999). "Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry." Am J Pathol 155(3): 739-752. 45.Lyden, D., K. Hattori, et al. (2001). "Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth." Nat Med 7(11): 1194-1201.
|